Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Zhou

OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs

Journal of Thoracic Oncology

English

P2.17-30 Serum Lipoprotein(A) Correlates With the Effect of Endostar Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced LSCC

Journal of Thoracic Oncology

English

P020 Characterization of Met Exon 14 Skipping and Association With Clinical Outcomes of Crizotinib in Chinese Lung Cancers

Journal of Thoracic Oncology

English

P1.01-61 Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers

Journal of Thoracic Oncology

English

P081 Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients

Journal of Thoracic Oncology

English

P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions

Journal of Thoracic Oncology

English

P3.01-68 Early SBRT to the Primary Tumor May Overcome the Icotinib Resistance in Patients With Advanced NSCLC Harboring EGFR Mutations

Journal of Thoracic Oncology

English

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

Journal of Thoracic Oncology

English

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

MA26.05 Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients With Different ALK Fusion-Variants

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Zhou

OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs

P2.17-30 Serum Lipoprotein(A) Correlates With the Effect of Endostar Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced LSCC

P020 Characterization of Met Exon 14 Skipping and Association With Clinical Outcomes of Crizotinib in Chinese Lung Cancers

P1.01-61 Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers

P081 Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients

P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions

P3.01-68 Early SBRT to the Primary Tumor May Overcome the Icotinib Resistance in Patients With Advanced NSCLC Harboring EGFR Mutations

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

P3.04-21 Antibiotics Attenuate the Clinical Benefit of Anti-Pd-(L)1 Immunotherapies in Chinese Patients With Advanced Non-Small Cell Lung Cancer

MA26.05 Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients With Different ALK Fusion-Variants